Seqirus’ Influenza Vaccine Manufacturing Facility, Melbourne

SEQIRUS Australia has Released a tender for Seqirus’ Influenza Vaccine Manufacturing Facility, Melbourne in Laboratory Equipment and Services. The tender was released on Jan 01, 1970.

Country - Australia

Summary - Seqirus’ Influenza Vaccine Manufacturing Facility, Melbourne

Deadline - Jun 30, 2026

MT reference number - 10264216

Product classification -

Organization Details:

  Address - Australia

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 10264216

  Document Type - Tender Notices

Notice Details and Documents:

Description - Location : Melbourne, Victoria, AustraliaSeqirus, an influenza vaccine maker, is building a new cell-based influenza vaccine manufacturing facility in Melbourne, Australia.The facility will be a significant addition to the company’s global manufact uring and supply chain for the influenza vaccine, including the facilities in Holly Springs, North Carolina, US, Liverpool, UK, and Parkville, Australia.The new plant will be utilised to manufacture influenza vaccines for both pandemics and seasonal vaccination programmes, using advanced cell-based technology. It will produce products for the domestic market and export, help Victoria’s 1,000+ STEM workers, and have an estimated supply chain of

Mt Ref Id - 10264216

Deadline - Jun 30, 2026

Share

View more tenders for

Australia Tenders